CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
2011-2012 Fluzone IIV3 (IM)biological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02987374
NCT02987374Phase 4Completed
CompareCT.gov

Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization

Stanford University·interventional·Posted Dec 8, 2016·Updated Apr 21, 2017

In Brief

A Phase 4 clinical trial evaluating 2011-2012 Fluzone IIV3 (IM) for Influenza. Completed, enrolled 10 participants.

Detailed Summary

The purpose is to investigate B-cell response to the trivalent Influenza Vaccine (TIV) in healthy young adults by vaccinating participants and obtaining blood samples at designated time points before and after vaccination.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
Countries--
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2016
Enrollment StartMay 1, 2012
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.6 years ago

Interventions

2011-2012 Fluzone IIV3 (IM)biological

2011-2012 Fluzone IIV3 vaccine delivered intramuscularly (IM)